LNSR Q2 2022 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+1.5% YoY

Gross Profit

$5M60.9% margin

Operating Income

-$7M-84.6% margin

Net Income

-$7M-84.1% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-13.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$59M

Total Liabilities

$14M

Stockholders' Equity

$45M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+1.5%
Gross Profit	$5M	$4M	+9.7%
Operating Income	-$7M	-$4M	-55.4%
Net Income	-$7M	-$4M	-55.0%

Revenue Segments

Product

$6M87%

Service

$890,00013%

Geographic Segments

UNITED STATES

$4M62%

Europe

$956,00014%

Asia Excluding South Korea

$771,00012%

KOREA, REPUBLIC OF

$662,00010%

Other Geographical Region

$137,0002%